| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | Interim CEO | Chief Commercial Officer
1 company
Wettig Thane is a CEO at FIBROGEN INC. Recent SEC Form 4 filings include 5 buys and 9 sells.
Estimated insider holdings value: $175K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | KYNB Fibrogen Inc | CEO | Buy | 3,700 | $9.12 | $33,749.73 | +8.5% | -15.7% | - | |
| Mar 24, 2025 | KYNB Fibrogen Inc | CEO | Buy | 145,000 | $0.35 | $50,663.00 | +36.4% | -41.5% | -26.8% | |
| Mar 7, 2024 | KYNB Fibrogen Inc | CEO | Buy | 50,000 | $1.91 | $95,470.00 | +11.9% | -32.4% | -79.3% | |
| Jun 23, 2023 | KYNB Fibrogen Inc | Chief Commercial Officer | Sell | 791 | $16.53 | $13,074.99 | -0.7% | -94.8% | -93.0% | |
| Jun 7, 2023 | KYNB Fibrogen Inc | Chief Commercial Officer | Sell | 1,758 | $17.04 | $29,951.29 | -0.8% | -93.8% | -93.1% | |
| Mar 23, 2023 | KYNB Fibrogen Inc | Chief Commercial Officer | Sell | 905 | $18.71 | $16,932.55 | -0.8% | -8.9% | -86.2% | |
| Mar 10, 2023 | KYNB Fibrogen Inc | Chief Commercial Officer | Sell | 13,934 | $20.63 | $287,434.81 | -4.0% | -11.6% | -91.1% | |
| Dec 23, 2022 | KYNB Fibrogen Inc | Chief Commercial Officer | Sell | 734 | $15.80 | $11,597.20 | -0.8% | +19.6% | -95.1% | |
| Dec 8, 2022 | KYNB Fibrogen Inc | Chief Commercial Officer | Sell | 382 | $15.79 | $6,031.78 | -0.4% | +39.7% | -95.9% | |
| Aug 26, 2021 | KYNB Fibrogen Inc | Chief Commercial Officer | Buy | 3,100 | $11.53 | $35,743.00 | +6.8% | +12.7% | +15.7% |